Yadav Santosh Kumar, Mishra Paras Kumar
Department of Cellular and Integrative Physiology, University of Nebraska Medical Center, Omaha, NE, USA.
Department of Anesthesiology, University of Nebraska Medical Center, Omaha, NE, USA.
Methods Mol Biol. 2018;1842:183-191. doi: 10.1007/978-1-4939-8697-2_12.
Despite several strategies developed for replenishing the dead myocardium after myocardial infarction (MI), stem cell therapy remains the leading method to regenerate new myocardium. Although induced pluripotent stem cells (iPS) and transdifferentiation of the differentiated cells have been used as novel approaches for myocardial regeneration, these approaches did not yield very successful results for myocardial regeneration in in vivo studies. Asynchronous contractility of newly formed cardiomyocytes with the existing cardiomyocytes is the most important issue with iPS approach, while very low yield of transdifferentiated cardiomyocytes and their less chances to beat in the same rhythm as existing cardiomyocytes in the MI heart are important caveats with transdifferentiation approach. CSCs are present in the heart and they have the potential to differentiate into myocardial cells. However, the number of resident CSCs is very low. Therefore, it is important to get maximum yield of CSCs during isolation process from the heart. Increasing the number of CSCs and initiating their differentiation ex vivo are crucial for CSC-based stem cell therapy. Here, we present a better method for isolation, characterization and differentiation of CSCs from the mouse heart. We also demonstrated morphological changes in the CSCs after 2 days, 3 days, and 7 days in maintenance medium and a separate group of CSCs cultured for 12 days in differentiation medium using Phase-Contrast microscopy. We have used different markers for identification of CSCs isolated from the mouse heart such as marker for mouse CSC, Sca-1, cardiac-specific markers NKX2-5, MEF2C, GATA4, and stemness markers OCT4 and SOX2. To characterize the differentiated CSCs, we used CSCs maintained in differentiation medium for 12 days. To evaluate differentiation of CSCs, we determined the expression of cardiomyocyte-specific markers actinin and troponin I. Overall; we described an elegant method for isolation, identification, differentiation and characterization of CSCs from the mouse heart.
尽管针对心肌梗死(MI)后坏死心肌的补充已开发出多种策略,但干细胞疗法仍是再生新心肌的主要方法。虽然诱导多能干细胞(iPS)以及分化细胞的转分化已被用作心肌再生的新方法,但在体内研究中,这些方法在心肌再生方面并未取得非常成功的结果。新形成的心肌细胞与现有心肌细胞的异步收缩性是iPS方法最重要的问题,而转分化心肌细胞的产量极低以及它们在MI心脏中与现有心肌细胞以相同节律跳动的机会较少是转分化方法的重要注意事项。心脏中存在心脏干细胞(CSCs),它们具有分化为心肌细胞的潜力。然而,驻留CSCs的数量非常少。因此,在从心脏分离过程中获得最大产量的CSCs很重要。增加CSCs的数量并在体外启动它们的分化对于基于CSC的干细胞疗法至关重要。在此,我们提出了一种从小鼠心脏分离、鉴定和分化CSCs的更好方法。我们还使用相差显微镜展示了在维持培养基中培养2天、3天和7天以及在分化培养基中培养12天的另一组CSCs的形态变化。我们使用了不同的标志物来鉴定从小鼠心脏分离的CSCs,例如小鼠CSC标志物Sca-1、心脏特异性标志物NKX2-5、MEF2C、GATA4以及干性标志物OCT4和SOX2。为了表征分化的CSCs,我们使用在分化培养基中维持12天的CSCs。为了评估CSCs的分化,我们测定了心肌细胞特异性标志物肌动蛋白和肌钙蛋白I的表达。总体而言,我们描述了一种从小鼠心脏分离、鉴定、分化和表征CSCs的精妙方法。